Global pharmaceutical & biopharmaceutical contract manufacturing market is expected to register significant growth during the forecast period owing to increasing investments in healthcare sector and growing demand for generic medicines. Further, the increasing investment in advanced manufacturing technologies by Contract Development & Manufacturing Organizations (CDMOs) is a major factor, which is anticipated to drive the market growth in coming years. Also, increasing drug development and manufacturing activities by pharmaceutical companies is propelling the growth of global pharmaceutical & biopharmaceutical contract manufacturing market.

Contract manufacturing is a form of outsourcing where a manufacturing company enters into an agreement with another manufacturing firm to develop innovative products and services. The recent outbreak of COVID-19 has pushed many pharma companies like Novartis and Johnson & Johnson to undergo a collaborative effort to find out the cure for this fatal virus. They are continuously carrying out research to find the suitable vaccine.

Global pharmaceutical & biopharmaceutical contract manufacturing market can be segmented based on sector, product type, service, drug type and region. Based on service type, the market is segmented into pharmaceutical manufacturing services, biologics manufacturing services and drug development services. The pharmaceutical manufacturing services is further segmented into pharmaceutical API manufacturing services and pharmaceutical FDF manufacturing services. Similarly, the biologics manufacturing services is segmented into biologic FDF manufacturing services and biologics API manufacturing services. Among these, the pharmaceutical manufacturing services holds largest market share and is expected to witness fastest growth during the forecast period. Increasing number of sterile formulations and intensive drug development activities are some key factors driving the growth of this segment.

Based on region, Asia Pacific is expected to register fastest growth during the forecast period owing to improving healthcare infrastructure and availability of highly skilled workforce. Many pharmaceutical companies are setting up their manufacturing units in countries such as China and India, which makes these countries hub for outsourcing.

Major companies operating in global pharmaceutical & biopharmaceutical contract manufacturing market include Jubilant Life Sciences Ltd, Catalent Inc., Integer Holdings Corp., Tecomet INC, West Pharmaceutical Services, Inc., Flex Ltd., Plexus Corp., Sanmina Corp., Patheon Inc., Cantel Medical Corp., Jabil, Inc., Pfizer Centresource, Angiplast Pvt. Ltd., Baxter Biopharma Solutions, Boehringer Ingelheim, Recipharm AB, Aesica Pharmaceuticals, Fareva Group, Vetter Pharma International, Synecco Ltd, among others. Leading companies are continuously carrying out research and development activities to bring new medicines. Also, favourable regulations by government in regions such as Asia Pacific is enabling manufacturers to expand their businesses efficiently.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021–2025

Objective of the Study:

  • To analyze and forecast the market size of global pharmaceutical & biopharmaceutical contract manufacturing market.
  • To forecast global pharmaceutical & biopharmaceutical contract manufacturing market based on sector, product type, service, drug type and regional distribution.
  • To identify drivers and challenges for global pharmaceutical & biopharmaceutical contract manufacturing market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions etc. in global pharmaceutical & biopharmaceutical contract manufacturing market.
  • To identify and analyze the profile of leading players operating in the global pharmaceutical & biopharmaceutical contract manufacturing market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of pharmaceutical & biopharmaceutical manufacturing companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research.

TechSci Research calculated global pharmaceutical & biopharmaceutical contract manufacturing market size using a bottom-up approach, where data for various end user industries and its application across various product types were recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analysing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used by TechSci Research.


Key Target Audience:

  • Pharmaceutical & biopharmaceutical manufacturers/companies and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, industry associations, forums and alliances related to pharmaceutical & biopharmaceutical contract manufacturing
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as pharmaceutical & biopharmaceutical contract manufacturing companies, partners, end users etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global pharmaceutical & biopharmaceutical contract manufacturing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Pharmaceutical & Biopharmaceutical Contract Manufacturing Market, By Sector:
    • Pharmaceutical
    • Biopharmaceutical
  • Global Pharmaceutical & Biopharmaceutical Contract Manufacturing Market, By Product Type:
    • Active Pharmaceutical Ingredients (API)
    • Finished Dosage Formulation
      • Tablet
      • Capsule
      • Oral Liquids
      • Parenteral/Injectables
      • Others
    • Advanced Drug Delivery Products
    • Over the Counter (OTC) Medicines
    • Nutritional Products
    • Others
  • Global Pharmaceutical & Biopharmaceutical Contract Manufacturing Market, By Service:
    • Pharmaceutical Manufacturing Services
      • Pharmaceutical API Manufacturing Services
      • Pharmaceutical FDF Manufacturing Services
    • Biologics Manufacturing Services
      • Biologics FDF Manufacturing Services
      • Biologics API Manufacturing Services
    • Drug Development Services
  • Global Pharmaceutical & Biopharmaceutical Contract Manufacturing Market, By Drug Type:
    • Originator / Patented
    • Generics
    • Biosimilar
  • Global Pharmaceutical & Biopharmaceutical Contract Manufacturing Market, By Region:
    • Asia-Pacific
      • China
      • Japan
      • India 
      • South Korea
      • Australia
      • Singapore
    • Europe
      • France
      • Germany
      • United Kingdom
      • Italy
      • Spain
    • North America
      • United States
      • Mexico
      • Canada
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • UAE
      • South Africa
      • Saudi Arabia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global pharmaceutical & biopharmaceutical contract manufacturing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Profit Margin Analysis

  • Profit margin analysis in case of direct and indirect sales channel.
It is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com  

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Pharmaceutical & Biopharmaceutical Contract Manufacturing Market

4.    Executive Summary

5.    Voice of Customer

6.    Global Pharmaceutical & Biopharmaceutical Contract Manufacturing Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Sector (Pharmaceutical, Biopharmaceutical)

6.2.2.     By Product Type (Active Pharmaceutical Ingredients (API), Finished Dosage Formulation (Tablet, Capsule, Oral Liquids, Parenteral/Injectables, Others), Advanced Drug Delivery Products, Over the Counter (OTC) Medicines, Nutritional Products, Others)

6.2.3.     By Service (Pharmaceutical Manufacturing Services (Pharmaceutical API Manufacturing Services, Pharmaceutical FDF Manufacturing Services), Biologics Manufacturing Services (Biologics FDF Manufacturing Services, Biologics API Manufacturing Services), Drug Development Services)

6.2.4.     By Drug Type (Originator / Patented, Generics, Biosimilar)

6.2.5.     By Company (2019)

6.2.6.     By Region

6.3.  Market Attractiveness Index

7.    Asia-Pacific Pharmaceutical & Biopharmaceutical Contract Manufacturing Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Sector

7.2.2.     By Product Type

7.2.3.     By Service

7.2.4.     By Drug Type

7.2.5.     By Country

7.3.  Competition Outlook

7.4.  Asia-Pacific: Country Analysis

7.4.1.     China Pharmaceutical & Biopharmaceutical Contract Manufacturing Market Outlook

7.4.1.1.         Market Size & Forecast

7.4.1.1.1.             By Value

7.4.1.2.         Market Share & Forecast

7.4.1.2.1.             By Sector

7.4.1.2.2.             By Product Type

7.4.1.2.3.             By Service

7.4.1.2.4.             By Drug Type

7.4.2.     India Pharmaceutical & Biopharmaceutical Contract Manufacturing Market Outlook

7.4.2.1.         Market Size & Forecast

7.4.2.1.1.             By Value

7.4.2.2.         Market Share & Forecast

7.4.2.2.1.             By Sector

7.4.2.2.2.             By Product Type

7.4.2.2.3.             By Service

7.4.2.2.4.             By Drug Type

7.4.3.     Japan Pharmaceutical & Biopharmaceutical Contract Manufacturing Market Outlook

7.4.3.1.         Market Size & Forecast

7.4.3.1.1.             By Value

7.4.3.2.         Market Share & Forecast

7.4.3.2.1.             By Sector

7.4.3.2.2.             By Product Type

7.4.3.2.3.             By Service

7.4.3.2.4.             By Drug Type

7.4.4.     South Korea Pharmaceutical Contract Manufacturing Market Outlook

7.4.4.1.         Market Size & Forecast

7.4.4.1.1.             By Value

7.4.4.2.         Market Share & Forecast

7.4.4.2.1.             By Sector

7.4.4.2.2.             By Product Type

7.4.4.2.3.             By Service

7.4.4.2.4.             By Drug Type

7.4.5.     Australia Pharmaceutical Contract Manufacturing Market Outlook

7.4.5.1.         Market Size & Forecast

7.4.5.1.1.             By Value

7.4.5.2.         Market Share & Forecast

7.4.5.2.1.             By Sector

7.4.5.2.2.             By Product Type

7.4.5.2.3.             By Service

7.4.5.2.4.             By Drug Type

7.4.6.     Singapore Pharmaceutical Contract Manufacturing Market Outlook

7.4.6.1.         Market Size & Forecast

7.4.6.1.1.             By Value

7.4.6.2.         Market Share & Forecast

7.4.6.2.1.             By Sector

7.4.6.2.2.             By Product Type

7.4.6.2.3.             By Service

7.4.6.2.4.             By Drug Type

8.    Europe Pharmaceutical Contract Manufacturing Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Sector

8.2.2.     By Product Type

8.2.3.     By Service

8.2.4.     By Drug Type

8.2.5.     By Country

8.3.  Competition Outlook

8.4.  Europe: Country Analysis

8.4.1.     France Pharmaceutical Contract Manufacturing Market Outlook

8.4.1.1.         Market Size & Forecast

8.4.1.1.1.             By Value

8.4.1.2.         Market Share & Forecast

8.4.1.2.1.             By Sector

8.4.1.2.2.             By Product Type

8.4.1.2.3.             By Service

8.4.1.2.4.             By Drug Type

8.4.2.     Germany Pharmaceutical Contract Manufacturing Market Outlook

8.4.2.1.         Market Size & Forecast

8.4.2.1.1.             By Value

8.4.2.2.         Market Share & Forecast

8.4.2.2.1.             By Sector

8.4.2.2.2.             By Product Type

8.4.2.2.3.             By Service

8.4.2.2.4.             By Drug Type

8.4.3.     United Kingdom Pharmaceutical Contract Manufacturing Market Outlook

8.4.3.1.         Market Size & Forecast

8.4.3.1.1.             By Value

8.4.3.2.         Market Share & Forecast

8.4.3.2.1.             By Sector

8.4.3.2.2.             By Product Type

8.4.3.2.3.             By Service

8.4.3.2.4.             By Drug Type

8.4.4.     Italy Pharmaceutical Contract Manufacturing Market Outlook

8.4.4.1.         Market Size & Forecast

8.4.4.1.1.             By Value

8.4.4.2.         Market Share & Forecast

8.4.4.2.1.             By Sector

8.4.4.2.2.             By Product Type

8.4.4.2.3.             By Service

8.4.4.2.4.             By Drug Type

8.4.5.     Spain Pharmaceutical Contract Manufacturing Market Outlook

8.4.5.1.         Market Size & Forecast

8.4.5.1.1.             By Value

8.4.5.2.         Market Share & Forecast

8.4.5.2.1.             By Sector

8.4.5.2.2.             By Product Type

8.4.5.2.3.             By Service

8.4.5.2.4.             By Drug Type

9.    North America Pharmaceutical Contract Manufacturing Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Sector

9.2.2.     By Product Type

9.2.3.     By Service

9.2.4.     By Drug Type

9.2.5.     By Country

9.3.  Competition Outlook

9.4.  North America: Country Analysis

9.4.1.     United States Pharmaceutical Contract Manufacturing Market Outlook

9.4.1.1.         Market Size & Forecast

9.4.1.1.1.             By Value

9.4.1.2.         Market Share & Forecast

9.4.1.2.1.             By Product Type

9.4.1.2.2.             By Service

9.4.1.2.3.             By Application

9.4.1.2.4.             By End User

9.4.2.     Mexico Pharmaceutical Contract Manufacturing Market Outlook

9.4.2.1.         Market Size & Forecast

9.4.2.1.1.             By Value

9.4.2.2.         Market Share & Forecast

9.4.2.2.1.             By Sector

9.4.2.2.2.             By Product Type

9.4.2.2.3.             By Service

9.4.2.2.4.             By Drug Type

9.4.3.     Canada Pharmaceutical Contract Manufacturing Market Outlook

9.4.3.1.         Market Size & Forecast

9.4.3.1.1.             By Value

9.4.3.2.         Market Share & Forecast

9.4.3.2.1.             By Sector

9.4.3.2.2.             By Product Type

9.4.3.2.3.             By Service

9.4.3.2.4.             By Drug Type

10.  South America Pharmaceutical Contract Manufacturing Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Sector

10.2.2.  By Product Type

10.2.3.  By Service

10.2.4.  By Drug Type

10.2.5.  By Country

10.3.              Competition Outlook

10.4.              South America: Country Analysis

10.4.1.  Brazil Pharmaceutical Contract Manufacturing Market Outlook

10.4.1.1.      Market Size & Forecast

10.4.1.1.1.           By Value

10.4.1.2.      Market Share & Forecast

10.4.1.2.1.           By Sector

10.4.1.2.2.           By Product Type

10.4.1.2.3.           By Service

10.4.1.2.4.           By Drug Type

10.4.2.  Argentina Pharmaceutical Contract Manufacturing Market Outlook

10.4.2.1.      Market Size & Forecast

10.4.2.1.1.           By Value

10.4.2.2.      Market Share & Forecast

10.4.2.2.1.           By Sector

10.4.2.2.2.           By Product Type

10.4.2.2.3.           By Service

10.4.2.2.4.           By Drug Type

10.4.3.  Colombia Pharmaceutical Contract Manufacturing Market Outlook

10.4.3.1.      Market Size & Forecast

10.4.3.1.1.           By Value

10.4.3.2.      Market Share & Forecast

10.4.3.2.1.           By Sector

10.4.3.2.2.           By Product Type

10.4.3.2.3.           By Service

10.4.3.2.4.           By Drug Type

11.  Middle East and Africa Pharmaceutical Contract Manufacturing Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Sector

11.2.2.  By Product Type

11.2.3.  By Service

11.2.4.  By Drug Type

11.2.5.  By Country

11.3.              Competition Outlook

11.4.              MEA: Country Analysis

11.4.1.  South Africa Pharmaceutical Contract Manufacturing Market Outlook

11.4.1.1.      Market Size & Forecast

11.4.1.1.1.           By Value

11.4.1.2.      Market Share & Forecast

11.4.1.2.1.           By Sector

11.4.1.2.2.           By Product Type

11.4.1.2.3.           By Service

11.4.1.2.4.           By Drug Type

11.4.2.  Saudi Arabia Pharmaceutical Contract Manufacturing Market Outlook

11.4.2.1.      Market Size & Forecast

11.4.2.1.1.           By Value

11.4.2.2.      Market Share & Forecast

11.4.2.2.1.           By Sector

11.4.2.2.2.           By Product Type

11.4.2.2.3.           By Service

11.4.2.2.4.           By Drug Type

11.4.3.  UAE Pharmaceutical Contract Manufacturing Market Outlook

11.4.3.1.      Market Size & Forecast

11.4.3.1.1.           By Value

11.4.3.2.      Market Share & Forecast

11.4.3.2.1.           By Sector

11.4.3.2.2.           By Product Type

11.4.3.2.3.           By Service

11.4.3.2.4.           By Drug Type

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Competition Outlook

14.2.              Players Profiled (Leading Companies)

14.2.1.  Jubilant Life Sciences Ltd

14.2.2.  Catalent Inc.

14.2.3.  Integer Holdings Corp.

14.2.4.  Tecomet INC

14.2.5.  West Pharmaceutical Services, Inc.

14.2.6.  Flex Ltd.

14.2.7.  Plexus Corp.

14.2.8.  Sanmina Corp.

14.2.9.  Patheon Inc.

14.2.10.                Cantel Medical Corp.

14.2.11.                Jabil, Inc.

14.2.12.                Pfizer Centresource

14.2.13.                Angiplast Pvt. Ltd.

14.2.14.                Baxter Biopharma Solutions

14.2.15.                Boehringer Ingelheim

14.2.16.                Recipharm AB

14.2.17.                Aesica Pharmaceuticals

14.2.18.                Fareva Group

14.2.19.                Vetter Pharma International

14.2.20.                Synecco Ltd

15.  Strategic Recommendations

16. About Us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com